Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Deferred Taxes (2020 - 2021)

Insight Molecular Diagnostics' Deferred Taxes history spans 2 years, with the latest figure at $97000.0 for Q4 2021.

  • For Q4 2021, Deferred Taxes rose 161.01% year-over-year to $97000.0; the TTM value through Dec 2021 reached -$9.3 million, down 638.52%, while the annual FY2021 figure was -$9.3 million, 638.52% down from the prior year.
  • Deferred Taxes for Q4 2021 was $97000.0 at Insight Molecular Diagnostics, up from -$1.8 million in the prior quarter.
  • Across five years, Deferred Taxes topped out at $97000.0 in Q4 2021 and bottomed at -$7.6 million in Q1 2021.